140 related articles for article (PubMed ID: 35415847)
1. Plasma proteomic analysis reveals altered protein abundances in HIV-infected patients with or without non-Hodgkin lymphoma.
Zhuang K; Zhang Y; Mo P; Deng L; Jiang Y; Yu L; Mei F; Huang S; Chen X; Yan Y; Tang H; Li X; Xiong Y; Wu S; Ke H; Gui X; Lan K
J Med Virol; 2022 Aug; 94(8):3876-3889. PubMed ID: 35415847
[TBL] [Abstract][Full Text] [Related]
2. A novel plasma proteomic-based model for predicting liver fibrosis in HIV/HBV co-infected adults.
Yuan R; Zhang Y; Deng L; Yu X; Zhuang K; Chen X; Cao Q; Ping H; Ke H; Gui X; Yang R
J Med Virol; 2023 Jan; 95(1):e28222. PubMed ID: 36237173
[TBL] [Abstract][Full Text] [Related]
3. Hodgkin disease developing in patients infected by human immunodeficiency virus results in clinical features and a prognosis similar to those in patients with human immunodeficiency virus-related non-Hodgkin lymphoma.
Re A; Casari S; Cattaneo C; Facchetti F; Cadeo G; Carosi G; Rossi G
Cancer; 2001 Dec; 92(11):2739-45. PubMed ID: 11753946
[TBL] [Abstract][Full Text] [Related]
4. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster.
Wang T; Shen H; Deng H; Pan H; He Q; Ni H; Tao J; Liu S; Xu L; Yao M
J Proteomics; 2020 Aug; 225():103879. PubMed ID: 32585426
[TBL] [Abstract][Full Text] [Related]
5. Epidemiological investigation and proteomic profiling of typical TCM syndrome in HIV/AIDS immunological nonresponders.
Ji SX; Zheng YF; Li X; Li BX; Zou JX; Wang YT; Xia XY; Chen X; Hu QN; Wan TJ; Wen L; Feng QS
Anat Rec (Hoboken); 2023 Dec; 306(12):3106-3119. PubMed ID: 35775967
[TBL] [Abstract][Full Text] [Related]
6. Projections of the incidence of non-Hodgkin's lymphoma related to acquired immunodeficiency syndrome.
Gail MH; Pluda JM; Rabkin CS; Biggar RJ; Goedert JJ; Horm JW; Sondik EJ; Yarchoan R; Broder S
J Natl Cancer Inst; 1991 May; 83(10):695-701. PubMed ID: 2023270
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of serum microbial translocation biomarkers and risk of AIDS-related non-Hodgkin lymphoma.
Epeldegui M; Magpantay L; Guo Y; Halec G; Cumberland WG; Yen PK; Macatangay B; Margolick JB; Rositch AF; Wolinsky S; Martinez-Maza O; Hussain SK
AIDS; 2018 Apr; 32(7):945-954. PubMed ID: 29424776
[TBL] [Abstract][Full Text] [Related]
8. Assessment of pre-diagnosis biomarkers of immune activation and inflammation: insights on the etiology of lymphoma.
Vendrame E; Martínez-Maza O
J Proteome Res; 2011 Jan; 10(1):113-9. PubMed ID: 20886858
[TBL] [Abstract][Full Text] [Related]
9. Serum protein biomarkers for HCC risk prediction in HIV/HBV co-infected people: a clinical proteomic study using mass spectrometry.
Ke H; Yuan R; Liu H; Luo M; Hu H; Zhang E; Zhuang K; Yang Y; Yang R
Front Immunol; 2023; 14():1282469. PubMed ID: 38022651
[TBL] [Abstract][Full Text] [Related]
10. Proteomic Profiles and Biological Processes of Relapsed vs. Non-Relapsed Pediatric Hodgkin Lymphoma.
Repetto O; De Re V; Mussolin L; Tedeschi M; Elia C; Bianchi M; Buffardi S; Sala A; Burnelli R; Mascarin M
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32235718
[TBL] [Abstract][Full Text] [Related]
11. Extracellular vesicles as biomarkers for AIDS-associated non-Hodgkin lymphoma risk.
Martínez LE; Magpantay LI; Guo Y; Hegde P; Detels R; Hussain SK; Epeldegui M
Front Immunol; 2023; 14():1259007. PubMed ID: 37809067
[TBL] [Abstract][Full Text] [Related]
12. AIDS-related lymphoma of the oral cavity.
Colmenero C; Gamallo C; Pintado V; Patron M; Sierra I; Valencia E
Int J Oral Maxillofac Surg; 1991 Feb; 20(1):2-6. PubMed ID: 2019778
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of indolent non-Hodgkin lymphoma in patients with type 1 human immunodeficiency virus infection.
Levine AM; Sadeghi S; Espina B; Tulpule A; Nathwani B
Cancer; 2002 Mar; 94(5):1500-6. PubMed ID: 11920507
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France.
Bonnet F; Balestre E; Thiébaut R; Morlat P; Pellegrin JL; Neau D; Dabis F;
Clin Infect Dis; 2006 Feb; 42(3):411-7. PubMed ID: 16392091
[TBL] [Abstract][Full Text] [Related]
15. Definition of two distinct types of AIDS-associated non-Hodgkin lymphoma.
Boyle MJ; Swanson CE; Turner JJ; Thompson IL; Roberts J; Penny R; Cooper DA
Br J Haematol; 1990 Dec; 76(4):506-12. PubMed ID: 2265114
[TBL] [Abstract][Full Text] [Related]
16. Serological Assessment of 18 Pathogens and Risk of AIDS-Associated Non-Hodgkin Lymphoma.
Halec G; Waterboer T; Brenner N; Butt J; Hardy WD; DʼSouza G; Wolinsky S; Macatangay BJ; Pawlita M; Detels R; Martínez-Maza O; Hussain SK
J Acquir Immune Defic Syndr; 2019 Mar; 80(3):e53-e63. PubMed ID: 30531297
[TBL] [Abstract][Full Text] [Related]
17. Outcome in patients with non-hodgkin lymphoma and with or without human immunodeficiency virus infection.
Spina M; Carbone A; Vaccher E; Gloghini A; Talamini R; Cinelli R; Martellotta F; Tirelli U
Clin Infect Dis; 2004 Jan; 38(1):142-4. PubMed ID: 14679461
[TBL] [Abstract][Full Text] [Related]
18. B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma.
Breen EC; Hussain SK; Magpantay L; Jacobson LP; Detels R; Rabkin CS; Kaslow RA; Variakojis D; Bream JH; Rinaldo CR; Ambinder RF; Martinez-Maza O
Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1303-14. PubMed ID: 21527584
[TBL] [Abstract][Full Text] [Related]
19. Advances in the epidemiology of HIV-associated non-Hodgkin's lymphoma and other lymphoid neoplasms.
Franceschi S; Dal Maso L; La Vecchia C
Int J Cancer; 1999 Nov; 83(4):481-5. PubMed ID: 10508483
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of HIV-associated non-Hodgkin lymphoma.
Killebrew D; Shiramizu B
Curr HIV Res; 2004 Jul; 2(3):215-21. PubMed ID: 15279585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
